4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-039636
CEO and CFO bought 3,500 shares at $9.11 ($31,885)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-11-03 | Purchase | +3,500 | $9.11 | $31,885 | 5,307,677 | D |
| Open-market purchases · 3,500 sh · avg $9.11 · $31,885 | |||||||
Loading xslF345X05/ownership.xml…